Human dermal fibroblast-derived extracellular matrix reduces postinflammatory hyperpigmentation after fractional carbon dioxide laser facial resurfacing in Asians.
Sang-Min ChoiKwang-Sik KookJun ParkBark Lynn LewSoon-Hyo KwonPublished in: Journal of cosmetic dermatology (2023)
We suggest that human dermal fibroblast-derived ECM may be used as adjunctive therapy after fractional carbon dioxide resurfacing to prevent postinflammatory hyperpigmentation in Asians.